Immunotherapy and Biomarkers in Neurodegenerative Disorders (2016) Martin Ingelsson

Description

Explores the use of immunotherapy, targeting abnormal protein aggregates or inflammatory molecules, as a promising therapeutic strategy for neurodegenerative disorders. Discusses the significant unmet medical needs in this area and the application of immunomodulatory therapies, referencing conditions such as multiple sclerosis.